文献速递乳腺乳腺X线

乳腺癌筛查中当日诊断影像的差异:COVID-19大流行期间实施的即时判读筛查乳腺X线摄影项目的影响

Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
PubMed 文献 · AJR Am J Roentgenol · 2021-09-08

本研究回顾性分析了2019年和2020年6月至10月的筛查乳腺X线摄影检查,评估即时判读筛查项目对异常筛查后当日诊断影像的影响。实施后,当日诊断影像比例从14.8%升至60.7%,且消除了实施前存在的种族差异(调整OR 0.30变为0.92),异常判读率降低(5.0% vs 6.3%),癌症检出率和PPV1无显著差异。

要点

  • 即时判读项目使异常筛查后当日诊断影像比例从14.8%提高到60.7%。
  • 实施前非白人种族当日诊断影像 odds 显著低于白人(aOR 0.30),实施后无差异。
  • 异常判读率实施后显著降低(5.0% vs 6.3%),癌症检出率和PPV1无显著变化。

局限性

  • 回顾性研究设计
  • 单中心研究
  • 未报告其他潜在混杂因素

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. The need for second visits between screening mammography and diagnostic imaging contributes to disparities in the time to breast cancer diagnosis. During the COVID-19 pandemic, an immediate-read screening mammography program was implemented to reduce patient visits and decrease time to diagnostic imaging. OBJECTIVE. The purpose of this study was to measure the impact of an immediate-read screening program with focus on disparities in same-day diagnostic imaging after abnormal findings are made at screening mammography. METHODS. In May 2020, an immediate-read screening program was implemented whereby a dedicated breast imaging radiologist interpreted all screening mammograms in real time; patients received results before discharge; and efforts were made to perform any recommended diagnostic imaging during the visit (performed by different radiologists). Screening mammographic examinations performed from June 1, 2019, through October 31, 2019 (preimplementation period), and from June 1, 2020, through October 31, 2020 (postimplementation period), were retrospectively identified. Patient characteristics were recorded from the electronic medical record. Multivariable logistic regression models incorporating patient age, race and ethnicity, language, and insurance type were estimated to identify factors associated with same-day diagnostic imaging. Screening metrics were compared between periods. RESULTS. A total of 8222 preimplementation and 7235 postimplementation screening examinations were included; 521 patients had abnormal screening findings before implementation, and 359 after implementation. Before implementation, 14.8% of patients underwent same-day diagnostic imaging after abnormal screening mammograms. This percentage increased to 60.7% after implementation. Before implementation, patients who identified their race as other than White had significantly lower odds than patients who identified their race as White of undergoing same-day diagnostic imaging after receiving abnormal screening results (adjusted odds ratio, 0.30; 95% CI, 0.10-0.86; p = .03). After implementation, the odds of same-day diagnostic imaging were not significantly different between patients of other races and White patients (adjusted odds ratio, 0.92; 95% CI, 0.50-1.71; p = .80). After implementation, there was no significant difference in race and ethnicity between patients who underwent and those who did not undergo same-day diagnostic imaging after receiving abnormal results of screening mammography (p > .05). The rate of abnormal interpretation was significantly lower after than it was before implementation (5.0% vs 6.3%; p < .001). Cancer detection rate and PPV1 (PPV based on positive findings at screening examination) were not significantly different before and after implementation (p > .05). CONCLUSION. Implementation of the immediate-read screening mammography program reduced prior racial and ethnic disparities in same-day diagnostic imaging after abnormal screening mammograms. CLINICAL IMPACT. An immediate-read screening program provides a new paradigm for improved screening mammography workflow that allows more rapid diagnostic workup with reduced disparities in care.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Dontchos BN, Achibiri J, Mercaldo SF, et al. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic. AJR Am J Roentgenol. 2021. PMID: 34494449. doi:10.2214/AJR.21.26597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。